Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

APP Protein Family Signaling at the Synapse: Insights from Intracellular APP-Binding Proteins.

Guénette S, Strecker P, Kins S.

Front Mol Neurosci. 2017 Mar 30;10:87. doi: 10.3389/fnmol.2017.00087. eCollection 2017. Review.

2.

FE65 and FE65L1 share common synaptic functions and genetically interact with the APP family in neuromuscular junction formation.

Strecker P, Ludewig S, Rust M, Mundinger TA, Görlich A, Krächan EG, Mehrfeld C, Herz J, Korte M, Guénette SY, Kins S.

Sci Rep. 2016 May 11;6:25652. doi: 10.1038/srep25652.

3.

FE65 and FE65L1 amyloid precursor protein-binding protein compound null mice display adult-onset cataract and muscle weakness.

Suh J, Moncaster JA, Wang L, Hafeez I, Herz J, Tanzi RE, Goldstein LE, Guénette SY.

FASEB J. 2015 Jun;29(6):2628-39. doi: 10.1096/fj.14-261453. Epub 2015 Mar 10.

4.

Assessing the contribution of marine protected areas to the trophic functioning of ecosystems: a model for the Banc d'Arguin and the Mauritanian shelf.

Guénette S, Meissa B, Gascuel D.

PLoS One. 2014 Apr 11;9(4):e94742. doi: 10.1371/journal.pone.0094742. eCollection 2014.

5.

No major role for insulin-degrading enzyme in antigen presentation by MHC molecules.

Culina S, Mauvais FX, Hsu HT, Burgevin A, Guénette S, Moser A, van Endert P.

PLoS One. 2014 Feb 7;9(2):e88365. doi: 10.1371/journal.pone.0088365. eCollection 2014.

6.

Amyloid beta a4 precursor protein-binding family B member 1 (FE65) interactomics revealed synaptic vesicle glycoprotein 2A (SV2A) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) as new binding proteins in the human brain.

Nensa FM, Neumann MH, Schrötter A, Przyborski A, Mastalski T, Susdalzew S, Looβe C, Helling S, El Magraoui F, Erdmann R, Meyer HE, Uszkoreit J, Eisenacher M, Suh J, Guénette SY, Röhner N, Kögel D, Theiss C, Marcus K, Müller T.

Mol Cell Proteomics. 2014 Feb;13(2):475-88. doi: 10.1074/mcp.M113.029280. Epub 2013 Nov 27.

7.

Pain perception and anaesthesia in research frogs.

Guénette SA, Giroux MC, Vachon P.

Exp Anim. 2013;62(2):87-92. Review.

8.

FE65 as a link between VLDLR and APP to regulate their trafficking and processing.

Dumanis SB, Chamberlain KA, Jin Sohn Y, Jin Lee Y, Guénette SY, Suzuki T, Mathews PM, Pak DTs, Rebeck GW, Suh YH, Park HS, Hoe HS.

Mol Neurodegener. 2012 Mar 19;7:9. doi: 10.1186/1750-1326-7-9.

9.

FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing.

Suh J, Lyckman A, Wang L, Eckman EA, Guénette SY.

J Neurochem. 2011 Oct;119(2):377-88. doi: 10.1111/j.1471-4159.2011.07419.x. Epub 2011 Sep 20.

10.

A role for FE65 in controlling GnRH-1 neurogenesis.

Forni PE, Fornaro M, Guénette S, Wray S.

J Neurosci. 2011 Jan 12;31(2):480-91. doi: 10.1523/JNEUROSCI.4698-10.2011.

11.

Scenarios for global biodiversity in the 21st century.

Pereira HM, Leadley PW, Proença V, Alkemade R, Scharlemann JP, Fernandez-Manjarrés JF, Araújo MB, Balvanera P, Biggs R, Cheung WW, Chini L, Cooper HD, Gilman EL, Guénette S, Hurtt GC, Huntington HP, Mace GM, Oberdorff T, Revenga C, Rodrigues P, Scholes RJ, Sumaila UR, Walpole M.

Science. 2010 Dec 10;330(6010):1496-501. doi: 10.1126/science.1196624. Epub 2010 Oct 26. Review.

PMID:
20978282
12.

Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing.

Suh J, Im DS, Moon GJ, Ryu KS, de Silva R, Choi IS, Lees AJ, Guénette SY, Tanzi RE, Gwag BJ.

J Neurochem. 2010 Jul;114(1):160-70. doi: 10.1111/j.1471-4159.2010.06732.x. Epub 2010 Apr 3.

13.

Anesthetic properties of propofol in African clawed frogs (Xenopus laevis).

Guénette SA, Beaudry F, Vachon P.

J Am Assoc Lab Anim Sci. 2008 Sep;47(5):35-8.

14.
15.

APP at a glance.

Wolfe MS, Guénette SY.

J Cell Sci. 2007 Sep 15;120(Pt 18):3157-61. Review. No abstract available.

16.

HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation.

Huttunen HJ, Guénette SY, Peach C, Greco C, Xia W, Kim DY, Barren C, Tanzi RE, Kovacs DM.

J Biol Chem. 2007 Sep 21;282(38):28285-95. Epub 2007 Aug 6.

17.

Eugenol for anesthesia of African clawed frogs (Xenopus laevis).

Guénette SA, Hélie P, Beaudry F, Vachon P.

Vet Anaesth Analg. 2007 May;34(3):164-70.

PMID:
17444929
18.

Pharmacokinetics of eugenol and its effects on thermal hypersensitivity in rats.

Guénette SA, Ross A, Marier JF, Beaudry F, Vachon P.

Eur J Pharmacol. 2007 May 7;562(1-2):60-7. Epub 2007 Feb 1.

PMID:
17321520
19.

[Case of cutaneous necrosis in African clawed frogs Xenopus laevis after the topical application of eugenol].

Ross A, Guénette SA, Hélie P, Vachon P.

Can Vet J. 2006 Nov;47(11):1115-7. French.

20.

Pharmacokinetics and anesthetic activity of eugenol in male Sprague-Dawley rats.

Guenette SA, Beaudry F, Marier JF, Vachon P.

J Vet Pharmacol Ther. 2006 Aug;29(4):265-70.

PMID:
16846463
22.

FE65 interaction with the ApoE receptor ApoEr2.

Hoe HS, Magill LA, Guenette S, Fu Z, Vicini S, Rebeck GW.

J Biol Chem. 2006 Aug 25;281(34):24521-30. Epub 2006 Apr 25.

23.

Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development.

Guénette S, Chang Y, Hiesberger T, Richardson JA, Eckman CB, Eckman EA, Hammer RE, Herz J.

EMBO J. 2006 Jan 25;25(2):420-31. Epub 2006 Jan 12.

24.
25.

Mechanisms of Abeta clearance and catabolism.

Guénette SY.

Neuromolecular Med. 2003;4(3):147-60. Review.

PMID:
14716023
26.

Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1.

Chang Y, Tesco G, Jeong WJ, Lindsley L, Eckman EA, Eckman CB, Tanzi RE, Guénette SY.

J Biol Chem. 2003 Dec 19;278(51):51100-7. Epub 2003 Oct 3.

27.

Astrocytes: a cellular player in Abeta clearance and degradation.

Guénette SY.

Trends Mol Med. 2003 Jul;9(7):279-80. No abstract available.

PMID:
12900212
28.

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7. Epub 2003 Mar 12.

29.
30.

Towards sustainability in world fisheries.

Pauly D, Christensen V, Guénette S, Pitcher TJ, Sumaila UR, Walters CJ, Watson R, Zeller D.

Nature. 2002 Aug 8;418(6898):689-95. Review.

PMID:
12167876
31.

A role for APP in motility and transcription?

Guénette SY.

Trends Pharmacol Sci. 2002 May;23(5):203-5; discussion 205-6.

PMID:
12007991
32.

The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.

Kimberly WT, Zheng JB, Guénette SY, Selkoe DJ.

J Biol Chem. 2001 Oct 26;276(43):40288-92. Epub 2001 Sep 5.

33.

No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease.

Bertram L, Guénette S, Jones J, Keeney D, Mullin K, Crystal A, Basu S, Yhu S, Deng A, Rebeck GW, Hyman BT, Go R, McInnis M, Blacker D, Tanzi R.

Ann Neurol. 2001 Jan;49(1):114-6.

PMID:
11198280
34.

Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies.

Bertram L, Blacker D, Crystal A, Mullin K, Keeney D, Jones J, Basu S, Yhu S, Guénette S, McInnis M, Go R, Tanzi R.

Exp Gerontol. 2000 Dec;35(9-10):1353-61.

PMID:
11113613
35.

Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients.

Guénette SY, Bertram L, Crystal A, Bakondi B, Hyman BT, Rebeck GW, Tanzi RE, Blacker D.

Neurosci Lett. 2000 Dec 15;296(1):17-20.

PMID:
11099823
36.

Progress toward valid transgenic mouse models for Alzheimer's disease.

Guénette SY, Tanzi RE.

Neurobiol Aging. 1999 Mar-Apr;20(2):201-11. Review.

PMID:
10537029
37.

hFE65L influences amyloid precursor protein maturation and secretion.

Guénette SY, Chen J, Ferland A, Haass C, Capell A, Tanzi RE.

J Neurochem. 1999 Sep;73(3):985-93.

38.

Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.

Guénette SY, Chen J, Jondro PD, Tanzi RE.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10832-7.

39.

The gene defects responsible for familial Alzheimer's disease.

Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W.

Neurobiol Dis. 1996;3(3):159-68. Review.

PMID:
8980016
40.

Familial Alzheimer's chromosome 14 mutations.

Wasco W, Pettingell WP, Jondro PD, Schmidt SD, Gurubhagavatula S, Rodes L, DiBlasi T, Romano DM, Guenette SY, Kovacs DM, et al.

Nat Med. 1995 Sep;1(9):848. No abstract available.

PMID:
7585193
41.

Suppression of a conditional mutation in alpha-tubulin by overexpression of two checkpoint genes.

Guénette S, Magendantz M, Solomon F.

J Cell Sci. 1995 Mar;108 ( Pt 3):1195-204.

42.

Identification of a novel Brugia pahangi beta-tubulin gene (beta 2) and a 22-nucleotide spliced leader sequence on beta 1-tubulin mRNA.

Guénette S, Prichard RK, Matlashewski G.

Mol Biochem Parasitol. 1992 Feb;50(2):275-84.

PMID:
1741015
43.

Characterization of a beta-tubulin gene and a beta-tubulin gene products of Brugia pahangi.

Guénette S, Prichard RK, Klein RD, Matlashewski G.

Mol Biochem Parasitol. 1991 Feb;44(2):153-64.

PMID:
2052017
44.

Changing patterns in hospital-associated microorganisms.

Dunlop SG, Guenette SA.

Rocky Mt Med J. 1972 Oct;69(10):61-4. No abstract available.

PMID:
5083713
45.

Spread of pertussis by hospital staff.

Kurt TL, Yeager AS, Guenette S, Dunlop S.

JAMA. 1972 Jul 17;221(3):264-7. No abstract available.

PMID:
4338335
46.

["Microtiter" technic for VDRL].

Kasatiya SS, Guénette S.

Can J Public Health. 1971 Jan-Feb;62(1):61-2. French. No abstract available.

PMID:
5549203

Supplemental Content

Loading ...
Support Center